Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 16-Dec-20 4:02 PM View:  | Tcr2 Therapeutics Inc. (TCRR) | 14-Dec-20 | Option Exercise | 2,000 | $5.88 | $11,760.00 | 136% 1.47K to 3.47K | |
| 16-Dec-20 4:02 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 14-Dec-20 | Market Option Sale (Planned) | 2,000 | $35.00 | $70,000.00 | (58%) 3.47K to 1.47K | 45% |
| 19-Nov-20 5:00 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 17-Nov-20 | Option Exercise | 2,000 | $5.88 | $11,760.00 | 64% 3.14K to 5.14K | |
| 19-Nov-20 5:00 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 17-Nov-20 | Market Option Sale (Planned) | 2,000 | $30.00 | $60,000.00 | (39%) 5.14K to 3.14K | 36% |
| 19-Nov-20 5:00 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 17-Nov-20 | Market Sale (Planned) | 1,666 | $30.00 | $49,980.00 | (53%) 3.14K to 1.47K | 36% |
| 27-Mar-20 4:11 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 28-Feb-20 | Grant | 1,473 | $10.10 | $14,877.30 | 88% 1.67K to 3.14K | |
| 27-Mar-20 4:11 PM View: | Tcr2 Therapeutics Inc. (TCRR) | 30-Aug-19 | Grant | 1,666 | $12.75 | $21,241.50 | 100% 0 to 1.67K |